Breakthrough – Blocking the spread of brain cancer cells.

In Brain Cancer, Brain Science by Brainy Days Ahead

Treatment of glioblastoma, a deadly brain cancer, consists of surgical removal of the tumor, radiation and chemotherapy using the drug temozolomide (TMZ). But remaining glioblastoma cells missed during surgery are resistant to TMZ, resulting in the cancer’s eventual return and the patient’s death, often within a year. This study led by scientists at the Translational Genomics Research Institute (TGen) has identified a chemical compound, Aurintricarboxylic Acid (ATA), that in laboratory tests was shown to block remaining glioblastoma cells from invading normal brain tissue.